...Capital and existing investors LSP, Kurma Partners and VI Partners. Other undisclosed investors also participated. Xeltis...
...The European and Asian Xplore-I feasibility trial is also evaluating the valve. Xeltis AG, Zurich, Switzerland Jennie Walters Xeltis AG...

...Xeltis AG , Zurich, Switzerland Business: Cardiovascular Date announced: 2015-12-17 Note: Xeltis raised EUR3 million ($3.3...
...million ($36.7 million). Lifecare Partners and an undisclosed new private investor participated in the extension. Xeltis...

...Regenerative medicine play Xeltis AG (Zurich, Switzerland) raised EUR 27 million ($33.6 million) in a series B...
...New investor VI Partners and undisclosed existing investors, including family offices and angels, also participated. Xeltis...
...blood vessel matrices designed to stimulate natural tissue growth. CEO Laurent Grandidier told BioCentury that Xeltis...